Founded in 2013 by a neurosurgeon, former engineering patent examiner, and business developer, Arkis BioSciencesTM is a medical device company providing sophisticated surgical tools and implantables for advancing the neurosurgical treatments of intracranial hypertension arising from hydrocephalus, traumatic brain injury, and hemorrhagic stroke.
Chad Seaver, CEO, Arkis Biosciences, holds undergraduate and graduate degrees from the University of Tennessee. Since their founding Seaver and the team at Arkis have worked closely with the Joint Institute for Advanced Materials at Cherokee Farm.
Founded in 2013 as Smokie Robotics, AUBO Robotics manufactures lightweight collaborative robots for industrial and academic use. In 2016 the company introduced a name change AUBO Robotics. The company was developed in collaboration between three Phd professors from USA and China, to make a lightweight intelligent collaborative robot. This robot arm was specially designed with important functions from the start, combining state of the art technology with user friendliness to make this collaborative robot (Co-bot). AUBO Robotics holds several core patents and has strategic cooperation with several public companies leveraging the best of all new technology.
Civil & Environmental Consultants, Inc., provides innovative design solutions and integrated expertise in the primary practice areas of civil engineering, ecological sciences, environmental engineering and sciences, survey, waste management, and water resources. The firm is consistently ranked among the Top 500 Design Firms and Top 200 Environmental Firms by Engineering News-Record and has more than 20 offices across the United States, including Nashville and Sevierville in Tennessee.
The Heart Lung Vascular Institute’s (HLVI) Data Management and Research Department manages multiple national clinical registries (i.e. Society of Thoracic Surgeons, NCDR/American College of Cardiology, American Heart Association GWTG-Heart Failure and Vascular Quality Database). We utilize a Cardiovascular Information System to improve the care of our HLVI patients. We are quality and research driven to integrate the latest evidence-based practice into our service lines (Cardiology, Cardiothoracic Surgery, Pulmonary and Vascular Surgery). We utilize a quality management system in conjunction with the LEAN process to continuously monitor patient care outcomes and drive quality improvements. We provide evidence-based data and research to help design, implement, and improve our HLVI clinical pathways. We also monitor and study overall outcomes of our clinical pathways. These outcomes include Length of Stay, Mortality, Complications and Readmissions for heart failure, chronic obstructive pulmonary disease, myocardial infarction, cardiac devices, coronary artery bypass grafting, vascular services, etc.
Our department works in collaboration with physicians, nurses, respiratory therapists, cardiac/pulmonary rehabilitations specialists, etc. to monitor and measure clinical performance. We also assist with process improvement projects, which in turn, lead to better patient outcomes. We provide data and guidance to the HLVI Performance Improvement committees and help identify improvement opportunities in patient care. We also use evidenced-based practices to drive improvements in our quality of care for our patients to acquire and maintain our national accreditations and certifications. We also support research endeavors including grant requests/writing, IRBs, assistance with clinical trials, and poster/manuscript publications.